Citations refer to the original publication, not to a Scieee localized version.
Marques, F. Z., Prestes, P. R., & Kähönen, M. (2019). Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. https://trepo.tuni.fi/handle/10024/117675
Marques, Francine Z., et al. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. 2019. https://trepo.tuni.fi/handle/10024/117675.
Marques, Francine Z., Priscilla R Prestes, and Mika Kähönen. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. 2019. https://trepo.tuni.fi/handle/10024/117675.
Marques, F. Z., Prestes, P. R. and Kähönen, M. (2019) Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. Available at: https://trepo.tuni.fi/handle/10024/117675.
F. Z. Marques, P. R. Prestes, and M. Kähönen, “Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure,” 2019. [Online]. Available: https://trepo.tuni.fi/handle/10024/117675
@misc{marques2019experimental,
author = {Marques, Francine Z. and Prestes, Priscilla R and Kähönen, Mika},
title = {Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure},
year = {2019},
url = {https://trepo.tuni.fi/handle/10024/117675}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.